West Pharmaceutical
248 hedge funds and large institutions have $3.66B invested in West Pharmaceutical in 2015 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 76 increasing their positions, 91 reducing their positions, and 14 closing their positions.
612% more call options, than puts
Call options by funds: $2.5M | Put options by funds: $351K
214% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 14
13% more funds holding
Funds holding: 219 → 248 (+29)
0.14% less ownership
Funds ownership: 94.01% → 93.87% (-0.14%)
7% less capital invested
Capital invested by funds: $3.93B → $3.66B (-$270M)
16% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 91
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$83M |
| 2 |
State Street
Boston,
Massachusetts
|
+$40.7M |
| 3 |
SCM
Sterling Capital Management
Charlotte,
North Carolina
|
+$37.8M |
| 4 |
Select Equity Group
New York
|
+$34M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$18.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$45M |
| 2 |
SM
Stratton Management
King Of Prussia,
Pennsylvania
|
-$40.8M |
| 3 |
KI
Kalmar Investments
Greenville,
Delaware
|
-$33.2M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$30.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$22.7M |
WST Hedge Fund Activity: Q3 2015 in Review
248 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2015, worth a combined $3.66B — down 6.9% from $3.93B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new WST positions and 14 closed out — a net gain of 30 holders — while 76 added to existing stakes and 91 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $83M. The largest seller was BlackRock Fund Advisors, cutting an estimated $45M.
- 248 institutional investors held West Pharmaceutical (WST) as of Q3 2015, up from 219 in Q2 2015.
- Funds reported $3.66B of West Pharmaceutical stock for Q3 2015, down 6.9% quarter-over-quarter.
- 44 funds opened new West Pharmaceutical positions in Q3 2015 and 14 closed out, a net change of +30 holders.
- The largest West Pharmaceutical buyer in Q3 2015 was T. Rowe Price Associates, an estimated $83M added.
- The largest West Pharmaceutical seller in Q3 2015 was BlackRock Fund Advisors, an estimated $45M sold.
Based on aggregated 13F filings for Q3 2015.